EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma

Conor D J O'Donnell iD, Umair Majeed, Michael S Rutenberg iD, Kristopher P Croome iD, Katherine E Poruk, Beau Toskich, Zhaohui Jin iD

Current Oncology · 31.01.2025 · 32 (2) · 82

DOI: 10.3390/curroncol32020082 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 31.01.2025. Verfasst von Conor D J O'Donnell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL 32224, USA. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intrahepatic cholangiocarcinoma is an aggressive malignancy with rising incidence and poor outcomes. This review examines recent advancements in locoregional therapies for unresectable intrahepatic cholangiocarcinoma, focusing on external beam radiotherapy, transarterial radioembolization (TARE), hepatic artery infusion pump (HAIP) chemotherapy, and liver transplantation. Stereotactic body radiation therapy and proton beam therapy have shown promise in achieving local control and improving survival. TARE, with personalized dosimetry, has demonstrated encouraging results in select patient populations. HAIP chemotherapy, primarily studied using floxuridine, has yielded impressive survival outcomes in phase II trials. Liver transplantation, once contraindicated, is now being reconsidered for carefully selected patients with localized disease. While these locoregional approaches show potential, randomized controlled trials comparing them to standard systemic therapy are lacking. Patient selection remains crucial, with factors such as liver function, tumor burden, and molecular profile influencing treatment decisions. Ongoing research aims to optimize treatment sequencing, explore combination strategies with systemic therapies, and refine phenotype identification and patient selection criteria. As the landscape of intrahepatic cholangiocarcinoma management evolves, a multidisciplinary approach is essential to tailor treatment strategies and improve outcomes for patients with this challenging disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsHumansCombined Modality Therapy

Stichwörter der Autor:innen

hepatic artery infusion pumpintrahepatic cholangiocarcinomaliver transplantationproton beam therapyselective internal radiation therapystereotactic body radiation therapy

Autor:innen und Institutionen

  • Department of Medicine, Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL 32224, USA.
  • Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL 32224, USA.
  • Department of Transplantation, Mayo Clinic Florida, Jacksonville, FL 32224, USA.
  • Department of Surgical Oncology, Mayo Clinic Florida, Jacksonville, FL 32224, USA.
  • Department of Interventional Radiology, Mayo Clinic Florida, Jacksonville, FL 32224, USA.
  • Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

ORCID-Profile: Conor D J O'Donnell, Michael S Rutenberg, Kristopher P Croome, Zhaohui Jin

Zitieren

APA

O'Donnell, C. D. J., Majeed, U., Rutenberg, M. S., Croome, K. P., Poruk, K. E., Toskich, B., & Jin, Z. (2025). Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma. Current Oncology, 32(2), 82. https://doi.org/10.3390/curroncol32020082

Vancouver

O'Donnell CDJ, Majeed U, Rutenberg MS, Croome KP, Poruk KE, Toskich B, et al. Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma. Current Oncology. 2025;32(2):82. doi:10.3390/curroncol32020082

BibTeX
@article{ODonnell2025,
  author = {O'Donnell, Conor D J and Majeed, Umair and Rutenberg, Michael S and Croome, Kristopher P and Poruk, Katherine E and Toskich, Beau and Jin, Zhaohui},
  title = {Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma},
  journal = {Current Oncology},
  year = {2025},
  volume = {32},
  number = {2},
  pages = {82},
  doi = {10.3390/curroncol32020082}
}
Kostenlos starten →